User talk:Beno Marija/MitO2 Kit Produktseite: Difference between revisions
Laner Verena (talk | contribs) No edit summary |
Laner Verena (talk | contribs) No edit summary Β |
||
(7 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
|product type=O2k | |product type=O2k | ||
|info=[[Image:MitoPedia.jpg|left|60px|link=http://www.bioblast.at/index.php/MitoPedia:_DatLab |MitoPedia: Mito-CII]] [[MitoPedia: Mito-CII]] | |info=[[Image:MitoPedia.jpg|left|60px|link=http://www.bioblast.at/index.php/MitoPedia:_DatLab |MitoPedia: Mito-CII]] [[MitoPedia: Mito-CII]] | ||
|product image= | |product image= Β | ||
}} | }} | ||
__TOC__ | __TOC__ | ||
Line 10: | Line 10: | ||
== Cell permeable compounds NV118 and NV161 - Mito-CII-Kit == | == Cell permeable compounds NV118 and NV161 - Mito-CII-Kit == | ||
=== Preparation === | |||
::::* The prodrug NV118 is dissolved in DMSO to 1M concentration and stored in aliquots at -20. | |||
::::* The prodrug NV161 is dissolved in DMSO to 1M concentration and stored in aliquots at -20. | |||
{{Publication | {{Publication | ||
|title=[[Image:O2k-Protocols.jpg|right|80px|link=http://wiki.oroboros.at/index.php/O2k-Protocols|O2k-Protocols]] Cell permeable compound - Mito-CII-Kit. Β | |title=[[Image:O2k-Protocols.jpg|right|80px|link=http://wiki.oroboros.at/index.php/O2k-Protocols|O2k-Protocols]] Cell permeable compound - Mito-CII-Kit. Β | ||
Line 16: | Line 23: | ||
|year=2019-03-01 | |year=2019-03-01 | ||
|journal=Mitochondr Physiol Network | |journal=Mitochondr Physiol Network | ||
|abstract=Gnaiger E, Laner V, Passrugger M, NeuroVive Pharmaceutical AB (2019) cell permeable compound - Mito-CII-Kit. Mitochondr Physiol Network 24.03(01):1-2. Β | |abstract=Gnaiger E, Bastos A, Laner V, Passrugger M, NeuroVive Pharmaceutical AB (2019) cell permeable compound - Mito-CII-Kit. Mitochondr Physiol Network 24.03(01):1-2. Β | ||
(##) The cell permeable compound Mito-CII-Kit is the first generation of NeuroVive Pharmaceutical AB's succinate/malonate prodrugs and was developed to stimulate and inhibit Complex II of the respiratory electron transfer system in intact cells, and will expand the toolbox for evaluating the role of mitochondria in disease. Β | (##) The cell permeable compound Mito-CII-Kit is the first generation of NeuroVive Pharmaceutical AB's succinate/malonate prodrugs and was developed to stimulate and inhibit Complex II of the respiratory electron transfer system in intact cells, and will expand the toolbox for evaluating the role of mitochondria in disease. Β | ||
Line 43: | Line 50: | ||
== Expiry date of Mito-CII== | == Expiry date of Mito-CII-Kit compounds (according to NeuroVive) == | ||
Β | |||
Β | |||
Before preparation: | |||
::::* 3 years in -80Β° C | |||
::::* 1 year in -20Β° C | |||
Β | |||
Β | |||
Prepared: | |||
::::* In DMSO solution | |||
::::::* at room temperature: 24 hours. | |||
::::::* at -20Β° C: for weeks | |||
::::* | CAS-Numbers: | ||
::::* | ::::* NV-118: 1592635-33-0 Β | ||
::::* NV-161: 1432752-62-9 Β | |||
Latest revision as of 14:16, 22 March 2019
User talk:Beno Marija/MitO2 Kit Produktseite
Description | Cell permeable compound - Mito-CII-Kit, 2 vials; 1 vial of NV118 (25 mg) + 1 vial of NV161 (10 mg) |
---|---|
Product ID | 60200-01 |
Type | O2k |
Link | MitoPedia: Mito-CII |
Image |
Compounds
Cell permeable compounds NV118 and NV161 - Mito-CII-Kit
Preparation
- The prodrug NV118 is dissolved in DMSO to 1M concentration and stored in aliquots at -20.
- The prodrug NV161 is dissolved in DMSO to 1M concentration and stored in aliquots at -20.
Cell permeable compound - Mito-CII-Kit. |
Β» Β» Versions
Oroboros (2019-03-01) Mitochondr Physiol Network
Abstract: Gnaiger E, Bastos A, Laner V, Passrugger M, NeuroVive Pharmaceutical AB (2019) cell permeable compound - Mito-CII-Kit. Mitochondr Physiol Network 24.03(01):1-2.
(##) The cell permeable compound Mito-CII-Kit is the first generation of NeuroVive Pharmaceutical AB's succinate/malonate prodrugs and was developed to stimulate and inhibit Complex II of the respiratory electron transfer system in intact cells, and will expand the toolbox for evaluating the role of mitochondria in disease.
- Β» Product: Oroboros O2k, O2k-Catalogue
β’ Keywords: Mito-CII-Kit
β’ O2k-Network Lab: AT_Innsbruck_Oroboros, NeuroVive
Compounds of Mito-CII-Kit
- The Mito-CII-Kit is composed of equal quantities of the following Compounds:
- Cell permeable compound NV118
- Description: Succinate prodrug: C10H14O8, Molecular weight 262,2g.mol-1
- Aliquots per 25 mg
- Cell permeable compound NV161
- Description: Malonate prodrug: C9H12O8, Molecular weight 248,2g.mol-1
- Aliquots per 10 mg
- Reference:
- Ehinger JK, Piel S, Ford R, Karlsson M, SjΓΆvall F, Frostner EΓ , Morota S, Taylor RW, Turnbull DM, Cornell C, Moss SJ, Metzsch C, Hansson MJ, Fliri H, ElmΓ©r E (2016) Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat Commun 7:12317. Β»Bioblast linkΒ« - Original publication introducing Mito-CII.
Expiry date of Mito-CII-Kit compounds (according to NeuroVive)
Before preparation:
- 3 years in -80Β° C
- 1 year in -20Β° C
Prepared:
- In DMSO solution
- at room temperature: 24 hours.
- at -20Β° C: for weeks
CAS-Numbers:
- NV-118: 1592635-33-0
- NV-161: 1432752-62-9
Labels: MiParea: Instruments;methods
HRR: O2k-Protocol
O2k-chemicals and media